2-(2-METHOXYETHYL)PHENYLBORONIC ACID, 95.0%, 250mg

tert-Butyl 1H-pyrazolo[3,4-b]pyridine-3-carboxylate, 97%, 5g

H-D-Tyr(tBu)-OH, 95%, 10g

1-Ethyl-5-nitro-1H-indazole, 95.0%, 100mg

2-Hydrazinyl-2-oxoacetamide, 97%, 1g

tert-butyl 3-oxo-2H,3H,3aH,4H,5H,6H,7H-pyrazolo[4,3-b]pyridine-4-carboxylate, 97%, 500mg

Ethyl 3-bromo-1-methyl-1H-pyrazole-4-carboxylate, 95.0%, 500mg

4,4'-(1,3,4-Oxadiazole-2,5-diyl)dianiline, 98%, 1g

9,9-Dimethyl-9,10-dihydroacridine, 95.0%, 5g

Sodium Glucoheptonate Dihydrate>98.0%(T)25g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid, 95.0%, 25g

4'-Bromo-4-biphenylboronic acid, 95.0%, 10g

Columnas de cromatografía con frita, núcleo de vidrio esmerilado y conexión de extracción GL 18, 120 ml, 20 mm, 400 mm, 1 Pieza(s)